Newer drugs and earlier treatment-Reference-Cited by-同舟云学术

Newer drugs and earlier treatment

Published:2012-01-02 Issue:1 Volume:26 Page:45-56
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Sloan Caroline E.,Champenois Karen,Choisy Philippe,Losina Elena,Walensky Rochelle P.,Schackman Bruce R.,Ajana Faiza,Melliez Hugues,Paltiel A.D.,Freedberg Kenneth A.,Yazdanpanah Yazdan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference40 articles.

1. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.;Jaggy;Lancet,2003

2. Survival of persons with and without HIV infection in Denmark, 1995-2005.;Lohse;Ann Intern Med,2007

3. Changes in the risk of death after HIV seroconversion compared with mortality in the general population.;Bhaskaran;JAMA,2008

4. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.;Thompson;JAMA,2010

5. The direct costs of HIVAIDS care.;Levy;Lancet Infect Dis,2006

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020;PLOS ONE;2024-07-26

2. Cost-effectiveness of drug consumption rooms in France: a modelling study;BMC Public Health;2024-05-28

3. De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study;HIV Medicine;2024-05-07

4. Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial;Swiss Medical Weekly;2024-04-15

5. Cost‐effectiveness of hepatitis C virus test‐and‐treat and risk reduction strategies among men who have sex with men living with HIV in France;Journal of the International AIDS Society;2022-11-30